Prelude Therapeutics Inc (PRLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 12,140 | 7,000 | 0 | 0 | 0 |
| Gross Profit | 12,140 | 7,000 | N/A | N/A | N/A |
| Operating Expenses | 116,706 | 146,714 | 132,277 | 123,540 | 113,735 |
| Operating Income | -104,566 | -139,714 | -132,277 | -123,540 | -113,735 |
| Other Income | 5,068 | 12,541 | 10,445 | 8,102 | 2,041 |
| Pre-tax Income | -99,498 | -127,173 | -121,832 | -115,438 | -111,694 |
| Net Income Continuous | -99,498 | -127,173 | -121,832 | -115,438 | -111,694 |
| Net Income | $-99,498 | $-127,173 | $-121,832 | $-115,438 | $-111,694 |
| EPS Basic Total Ops | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EPS Basic Continuous Ops | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EPS Diluted Total Ops | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EPS Diluted Continuous Ops | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EPS Diluted Before Non-Recurring Items | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 |
| EBITDA(a) | $-103,226 | $-142,581 | $-134,581 | $-119,625 | $-111,456 |